Centricity Laboratory Core Lab System 4.1 The Centricity Laboratory System is intended to be an information system designed to support the clinical and administrative activities associated with the provision and utilization of clinical laboratory services and facilities, e.g., the storing and delivering of analytical results. It is a specially designed data program application (software), which is supplied for installation in existing mainframe or decentralized computers or a computer network.
Publicado el 7 de septiembre de 2016 · Inicio del retiro: 20 de noviembre de 2012
Resumen
FDA registra el retiro Z-2671-2016 de dispositivos médicos de Clase II, publicado el 7 de septiembre de 2016 e iniciado el 20 de noviembre de 2012. Empresa responsable: GE Healthcare It; Estado: Finalizado; Cantidad reportada: 17; Lote: Versions 4.1, 4.0, 3.3.2 & 3.3Almp. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The Centricity Laboratory removes free-text notes on a master panel when the user deletes the slave panel. The deletion of a slave panel will (auto slash) the corresponding test (item) results on the master panel. Additionally, the displayed and HL7 results show neither the appropriate abnormal flag value nor the reference range values, when using large_num.g >7 to report numeric results.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- GE Healthcare It
- Distribuidor
- Worldwide Distribution - US Distribution to GA, OH, NY, TX, TN ,MN and Internationally to India, Australia, Canada, England, Qatar, and Scotland.
- Lote
- Versions 4.1, 4.0, 3.3.2 & 3.3Almp
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAPRESIDENT brand Authentic Pub Cheese SPREADABLE CHEESE, Cheddar & Porter Ale, Net Wt. 8 oz. (226g), UPC7 de septiembre de 2016
- FDASTAPLER,IS4000; Model number 470298; General and Plastic Surgery: The Intuitive Surgical da Vinci EndoWrist7 de septiembre de 2016
- FDAThe Centricity Laboratory System is intended to be an information system designed to support the clinical and5 de febrero de 2014
- FDAMerge Mammo is a multi-modality, vendor-neutral digital mammography workstation that enables imaging centers22 de enero de 2014
- FDAThe Centricity Laboratory System is intended to be an information system designed to support the clinical and8 de enero de 2014
- FDAThe Centricity Laboratory System is intended to be an information system designed to support the clinical and27 de noviembre de 2013
Preguntas sobre este retiro
¿Centricity Laboratory Core Lab System 4.1 The Centricity Laboratory System is intended to be an information system designed to support the clinical and administrative activities associated with the provision and utilization of clinical laboratory services and facilities, e.g., the storing and delivering of analytical results. It is a specially designed data program application (software), which is supplied for installation in existing mainframe or decentralized computers or a computer network. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2671-2016 el 7 de septiembre de 2016. Peligro reportado: The Centricity Laboratory removes free-text notes on a master panel when the user deletes the slave panel. The deletion of a slave panel will (auto slash) the corresponding test (item) results on the master panel. Additionally, the displayed and HL7 results show neither the appropriate abnormal flag value nor the reference range values, when using large_num.g >7 to report numeric results.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter